Tech stocks performed similarly to blue chips on the week. This is major news for both the fight against lung cancer and bysi stock.
A look at the stock’s price movement, the close in the last trading session was $13.32, moving within a range at $13.0
Beyond spring stock news. The early morning breaking of this news sent bysi stock down in premarket trading by 52%. Press release reported on 11/24/21 that beyondspring pharmaceuticals to present at This suggests a possible upside of 351.6% from the stock's current price.
Its median target price of $39 is a premium of 46.7%. It shows no signs of rebounding. Despite a minimal downtick, bysi stock had seen no serious.
It had slid 27% in the six months through tuesday. All six analysts polled by cnn business rate bysi stock as a buy or some equivalent. 1, 2021 at 7:58 a.m.
The price to earnings (p/e) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the. Do not follow this link! As soon as markets opened, it continued falling, and although it has remained stagnant within the last hour, the stock has fallen by almost 54% as of this writing.
The stock recently traded at $27.11, compared with its tuesday close at $9.63. Their forecasts range from $25.00 to $95.00. Beyondspring stock halted for news pending;
No news for in the past two years. Bysi), a global pharmaceutical company focused on the development of cancer therapeutics, today announced it has received a complete response letter (crl) from the u.s. Beyondspring now will take its case to the u.s.
Beyondspring inc stock is up 34.00% over the last 12 months, and the average rating from wall street analysts is a strong buy.investorsobserver’s proprietary ranking system, gives bysi stock a score of 82 out of a possible 100. The early morning breaking of this news sent bysi stock down in premarket trading by 52%. During friday's session, the dow jones industrial average increased 179 points, or 0.50%.
Press release reported on 12/02/21 that shareholder alert: Stock was up 4.5% premarket ahead of trading halt dec. Stock was up 4.5% premarket ahead of trading halt published:
Bysi's rank also includes a fundamental score of 84. On average, they anticipate beyondspring's share price to reach $58.75 in the next year. In the biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 26% of stocks.
The company’s stock price has collected 7.73% of gains in the last five trading sessions. Beyondspring inc has fallen 5.86% over the past month, closing at $14.72 on november 2. Market cap shares in issue float revenue profit/loss eps pe ratio;
The lowest target price of $37 is a premium of 39.2% over current prices. Stock advisor launched in february of 2002. Its street high target price of $100 implies an upside of 276% over the next 12 months.
Et by tomi kilgore beyondspring pharma shares drop 30% after data for. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. As soon as markets opened, it continued falling, and although it has remained stagnant within the last.
Beyondspring stock halted for news pending; 1, 2021 at 7:58 a.m.
